Author:
Lin Lee-Kai,Simon Kosali,Hollingsworth Alex,Saloner Brendan
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Christie C, Baker C, Cooper R, Kennedy CPJ, Madras B, Bondi FAGP. The president’s commission on combating drug addiction and the opioid crisis. Washington, DC, US Gov Print Off Nov. 2017;1.
2. Johnson K, Jones C, Compton W, Baldwin G, Fan J, Mermin J, et al. Federal response to the opioid crisis. Curr HIV/AIDS Rep 2018;15(4):293–301.
3. Wen H, Hockenberry JM, Pollack HA. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees. JAMA Netw Open 2018;1(5):e182943.
4. Jones CM, McCance-Katz EF. Characteristics and Prescribing Practices of Clinicians Recently Waivered to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder. Addiction. 2018;
5. Saloner B, Daubresse M, Caleb Alexander G. Patterns of buprenorphine-naloxone treatment for opioid use disorder in a multistate population. Med Care 2017;55(7):669–76.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献